M-A | Cardiovascular events in patients treated with bempedoic acid versus placebo
31 Jul, 2023 | 14:06h | UTC
Commentary on Twitter
Bempedoic acid for the prevention of cardiovascular events in patients with an indication for lipid-lowering therapy: a meta-analysis of 10 randomised trials https://t.co/PswEP3vj0K @AgewallStefan @FeliceGragnano #EHJPharmacotherapy #ESCYoung pic.twitter.com/0eYyBBWrDn
— European Society of Cardiology Journals (@ESC_Journals) July 29, 2023